Microphthalmia, Anophthalmia, and Coloboma Genetic Epidemiology in Children
Part of paid clinical trials in Houston, Texas.
- Sponsor
- Baylor College of Medicine
- Study ID
- NCT06293560
- Status
- Recruiting
Conditions
- Anophthalmia
- Coloboma
- Microphthalmia
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Accepted
Study Details
The investigators are inviting families to take part in a research study that will help us better understand the physical characteristics associated with children who have Microphthalmia, Anophthalmia, and Coloboma (MAC) and how changes in their DNA sequence, called genetic mutations, play a role in the risk of developing MAC
Key Dates
- Start date
- Sep 25, 2022
- Status verified
- Apr 2026
- Primary completion
- Sep 30, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 3,000 participants (estimated)
Primary Outcome Measure
Stage 1 [ Time Frame: End of study, on or before 12/31/2032 ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Baylor College of Medicine | Houston | Texas | 77030 | Philip Lupo, PhD, MPH (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By research site
Related Studies
- Pathogenesis and Genetics of Microphthalmia, Anophthalmia and Uveal Coloboma (MAC)Recruiting · National Eye Institute (NEI) · Bethesda, Maryland